M. Roobol

New England Journal of Medicine · 2009–2019

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom M. Roobol trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Ewout W. Steyerberg (in Artificial Intelligence)

Papers from M. Roobol's perspective

Ordered by how strongly the researchers M. Roobol trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests (British medical journal)
  2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. (The Lancet)
  3. A calibration hierarchy for risk models was defined: from utopia to empirical data. (Journal of Clinical Epidemiology)
  4. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (European Urology)
  5. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. (European Urology)
  6. The Statistical Analysis of Failure Time Data (Technometrics)
  7. Criteria for Evaluation of Novel Markers of Cardiovascular Risk (Circulation)
  8. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
  9. Clinical Prediction Models (Statistics for Biology and Health)
  10. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. (Journal of the National Cancer Institute)

Their papers